SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-18-358131
Filing Date
2018-12-26
Accepted
2018-12-26 16:31:35
Documents
6
Period of Report
2018-11-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d677625d8ka.htm 8-K/A 17824
2 EX-10.1 d677625dex101.htm EX-10.1 796938
3 EX-99.1 d677625dex991.htm EX-99.1 15273
4 GRAPHIC g677625g1222041302866.jpg GRAPHIC 3897
5 GRAPHIC g677625g1222041303241.jpg GRAPHIC 4300
6 GRAPHIC g677625page159.jpg GRAPHIC 4161
  Complete submission text file 0001193125-18-358131.txt   848797
Mailing Address 675 W. KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 W. KENDALL STREET CAMBRIDGE MA 02142 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38327 | Film No.: 181252925
SIC: 2834 Pharmaceutical Preparations